Moon SH, Kim MH. Prophecy about post-endoscopic retrograde cholangiopancreatography pancreatitis: From divination to science.
World J Gastroenterol 2013;
19:631-637. [PMID:
23429236 PMCID:
PMC3574588 DOI:
10.3748/wjg.v19.i5.631]
[Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/15/2012] [Revised: 12/28/2012] [Accepted: 01/13/2013] [Indexed: 02/06/2023] Open
Abstract
One unresolved issue of endoscopic retrograde cholangiopancreatography (ERCP) is post-ERCP pancreatitis (PEP), which occurs in up to 40% of patients. Identification of risk factors for PEP is especially important in the field of ERCP practice because it may assist physicians in taking protective measures in situations with high risk. A decade ago, Freeman et al meticulously evaluated a large number of potentially relevant risk factors for PEP, which can be divided into patient-related and procedure-related issues. In this commentary, we summarize this classic article and reevaluate the risk factors for PEP from the current point of view. This is followed by assessment of strategies for prevention of PEP that can be divided into mechanical and pharmacologic methods.
Collapse